Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2013 000 046.5 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | 4-Aminopyridin |
54 | Title of basic patent | TIGZ | Verfahren zur Verwendung von Aminopyridinzusammensetzugnen mit verzögerter Freisetzung |
51 | IPC main class | ICM (ICMV) | A61K 31/44 (2006.01) |
94 | Start of term of protection | LB | Apr 12, 2025 |
94 | End of term of protection | LE | Jul 25, 2026 |
22 | DE application date | DAT | Jun 14, 2013 |
| Date of publication of application for a certificate | OT | Aug 14, 2013 |
71/73 | Applicant/owner | INH | Merz Pharmaceuticals, LLC, 6601 Six Forks Road, 4th Fl., 27615 Raleigh, NC, US |
74 | Representative | VTR | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE |
| Address for service | | Uexküll & Stolberg Partnerschaft von Patent- und Rechtsanwälten mbB, 22607 Hamburg, DE |
| Due date | FT FG | Apr 30, 2026 Annual fee for the 22nd year
Patent fees |
| Patent division in charge | | 43 |
68 | DE file number of basic patent | GAKZ | 60 2005 038 519.3 |
68 | EP file number of basic patent | GEAKZ | 11 16 0247.0 |
43 | Date of first publication | EVT | Aug 14, 2013 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/11/699/001-002 2011-07-20
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/699/001-002 2011-07-20
|
| Date of the first transfer into DPMAregister | EREGT | Aug 14, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | May 11, 2025 (Show all update days)(Hide all update days)- May 11, 2025
- Procedures: Supplementary protection certificate procedure, Certificate granted, 12.04.2025: new
- Apr 30, 2025
- Apr 15, 2025
- St.36: changed (technical change)
- Mar 11, 2025
- Due date: new
- Procedures: Supplementary protection certificate procedure, Decision to grant certificate by Patent Division, 10.03.2025: new
- Mar 7, 2025
- Product name: changed
- End of term of protection: new
- Sep 26, 2024
- Applicant/owner: changed
- Procedures: New applicant/owner details, New applicant/owner details, 25.09.2024: new
- Aug 12, 2024
- St.36: changed (technical change)
- Jul 16, 2019; Dec 3, 2016; Apr 13, 2016; Jul 11, 2015; Jul 5, 2014; May 3, 2014; Mar 1, 2014; Oct 3, 2013
- Historical data not available for this/these date(s)
- Aug 14, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Sep 25, 2024 |
71/73 | Applicant/owner | INH | Merz Pharmaceuticals, LLC, 27615 Raleigh, NC, US |
71/73 | Previous applicant/owner | INHF | Acorda Therapeutics, Inc., 10502 Ardsley, US |
| Date of update of the procedure | REGT | Sep 26, 2024 |